Repository hosted by TU Delft Library

Home · Contact · About · Disclaimer ·
 

Search results also available in MS Excel format.

Showing 1 to 3 of 3 found. | Sort by date

1 Dexamethasone-eluting stents for the prevention of in-stent restenosis: Evidence for a differential effect in insulin-dependent and non-insulin-dependent diabetic patients
article 2008    
Author: Hoeven, B.L. van der · Pires, N.M.M. · Warda, H.M. · Putter, H. · Quax, P.H.A. · Schalij, M.J. · Jukema, J.W.
Keywords: Health · Dexamethasone · Diabetes mellitus · Restenosis · dexamethasone · adult · aged · angiography · article · clinical article · drug eluting stent · dyslipidemia · female · follow up · heart infarction · human · hypertension · insulin dependent diabetes mellitus · male · non insulin dependent diabetes mellitus · priority journal · restenosis · revascularization · smoking · survival · Adolescent · Adult · Aged · Angioplasty, Transluminal, Percutaneous Coronary · Cohort Studies · Coronary Angiography · Coronary Restenosis · Coronary Stenosis · Dexamethasone · Diabetes Mellitus, Type 1 · Diabetes Mellitus, Type 2 · Diabetic Angiopathies · Drug-Eluting Stents · Female · Follow-Up Studies · Humans · Male · Middle Aged · Probability · Risk Assessment · Survival Rate · Treatment Outcome · Ultrasonography, Interventional
[Abstract]

2 Corrigendum to "Dexamethasone-eluting stents for the prevention of in-stent restenosis: Evidence for a differential effect in insulin-dependent and non-insulin-dependent diabetic patients” [Int. J. Cardiol. 124 (2008) 166-171] (Dexamethasone-eluting stents for the prevention of in-stent restenosis: Evidence for a differential effect in insulin-dependent and non-insulin-dependent diabetic patients (2008) 124(2) (166-171), (S0167527307003518), (10.1016/j.ijcard.2006.12.034))
article 2019    
Author: Hoeven, B.L. van der · Pires, N.M.M. · Warda, H.M. · Putter, H. · Quax, P.H.A. · Schalij, M.J. · Jukema, J.W.
Keywords: Erratum
[PDF] [Abstract]

3 Local perivascular delivery of anti-restenotic agents from a drug-eluting poly(ε-caprolactone) stent cuff
article 2005    
Author: Pires, N.M.M. · Hoeven, B.L. van der · Vries, M.R. de · Havekes, L.M. · Vlijmen, B.J. van · Hennink, W.E. · Quax, P.H.A. · Jukema, J.W.
Keywords: Biology · Biomedical Research · Animal model · Controlled drug release · Drug-eluting stents · Local delivery · Poly(ε-caprolactone) · Restenosis · Cardiology · Cell culture · Mathematical models · Muscle · Anti-restenotic agents · Contralateral femoral arteries · Drug-eluting stents (DES) · Interventional cardiology · Controlled drug delivery · Actin · Macrogol 300 · Macrogol derivative · Paclitaxel · Polycaprolactone · Polymer · Rapamycin · Unclassified drug · Animal experiment · Animal tissue · Artery intima proliferation · controlled study · Dose response · Drug delivery system · Drug formulation · Femoral artery · In vivo study · In-stent restenosis · Mouse · Nonhuman · Reproducibility · Smooth muscle fiber · Sustained drug release · Animals · Blood Vessel Prosthesis · Coated Materials, Biocompatible · Diffusion · Drug Carriers · Drug Implants · Femoral Artery · Graft Occlusion, Vascular · Immunosuppressive Agents · Male · Materials Testing · Mice · Mice, Inbred C57BL · Paclitaxel · Polyesters · Sirolimus · Stents · Animalia
[Abstract]

Search results also available in MS Excel format.

Showing 1 to 3 of 3 found. | Sort by date